iSpecimen Inc. Stock-Based Compensation
iSpecimen Inc. (ISPC) reported Stock-Based Compensation of $1.18 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-14
- iSpecimen Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $153.00, a 91.51% decline year-over-year.
- iSpecimen Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $1.03K, a 93.53% decline year-over-year.
- iSpecimen Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $1.76K, a 83.91% decline year-over-year.
- iSpecimen Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $1.80K, a 97.24% decline year-over-year.
- iSpecimen Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $21.27K, a 91.48% decline from fiscal 2024.
- iSpecimen Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $249.68K, a 45.68% decline from fiscal 2023.
- iSpecimen Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $459.67K, a 32.26% decline from fiscal 2022.
- iSpecimen Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $678.61K, a 9.09% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $153.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $1.18K 10-Q · filed 2026-08-14 | $2.95K derived: sum of 3 quarters · filed 2026-08-14 | $4.74K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $1.03K 10-Q · filed 2026-05-18 | $2.79K derived: sum of 2 quarters · filed 2026-05-18 | $4.59K derived: sum of 3 quarters · filed 2026-05-18 | $6.39K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $1.76K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $3.56K derived: sum of 2 quarters · filed 2026-04-01 | $5.37K derived: sum of 3 quarters · filed 2026-08-14 | $21.27K 10-K · filed 2026-04-01 |
| 2025-09-30 | $1.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | $3.60K derived: sum of 2 quarters · filed 2026-08-14 | $19.50K 10-Q · filed 2025-11-17 | $30.47K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $1.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $17.70K 10-Q · filed 2026-08-14 | $28.68K derived: sum of 3 quarters · filed 2026-08-14 | $93.82K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $15.90K 10-Q · filed 2026-05-18 | $26.87K derived: sum of 2 quarters · filed 2026-05-18 | $92.01K derived: sum of 3 quarters · filed 2026-05-18 | $171.65K derived: sum of 4 quarters · filed 2026-05-18 |
| 2024-12-31 | $10.97K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $76.11K derived: sum of 2 quarters · filed 2026-04-01 | $155.75K derived: sum of 3 quarters · filed 2026-04-01 | $249.68K 10-K · filed 2026-04-01 |
| 2024-09-30 | $65.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | $144.78K derived: sum of 2 quarters · filed 2025-11-17 | $238.70K 10-Q · filed 2025-11-17 | $346.82K derived: sum of 4 quarters · filed 2025-11-17 |
| 2024-06-30 | $79.64K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $173.56K 10-Q · filed 2025-08-14 | $281.68K derived: sum of 3 quarters · filed 2025-08-14 | $387.97K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $93.92K 10-Q · filed 2025-05-19 | $202.04K derived: sum of 2 quarters · filed 2025-05-19 | $308.34K derived: sum of 3 quarters · filed 2025-05-19 | $433.03K derived: sum of 4 quarters · filed 2025-05-19 |
| 2023-12-31 | $108.12K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-14 | $214.41K derived: sum of 2 quarters · filed 2025-04-14 | $339.11K derived: sum of 3 quarters · filed 2025-04-14 | $459.67K 10-K · filed 2025-04-14 |
| 2023-09-30 | $106.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $230.99K derived: sum of 2 quarters · filed 2024-11-07 | $351.55K 10-Q · filed 2024-11-07 | $396.69K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $124.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $245.25K 10-Q · filed 2024-08-06 | $290.39K derived: sum of 3 quarters · filed 2024-08-06 | $510.33K derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $120.56K 10-Q · filed 2024-05-07 | $165.69K derived: sum of 2 quarters · filed 2024-05-07 | $385.63K derived: sum of 3 quarters · filed 2024-05-07 | $614.98K derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $45.14K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $265.07K derived: sum of 2 quarters · filed 2024-03-13 | $494.42K derived: sum of 3 quarters · filed 2024-03-13 | $678.61K 10-K · filed 2024-03-13 |
| 2022-09-30 | $219.94K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $449.28K derived: sum of 2 quarters · filed 2023-11-02 | $633.48K 10-Q · filed 2023-11-02 | $805.31K derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | $229.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $413.54K 10-Q · filed 2023-08-02 | $585.37K derived: sum of 3 quarters · filed 2023-08-02 | $985.19K derived: sum of 4 quarters · filed 2023-08-02 |
| 2022-03-31 | $184.19K 10-Q · filed 2023-05-04 | $356.02K derived: sum of 2 quarters · filed 2023-05-04 | $755.85K derived: sum of 3 quarters · filed 2023-05-04 | $784.22K derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $171.83K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-30 | $571.65K derived: sum of 2 quarters · filed 2023-03-30 | $600.03K derived: sum of 3 quarters · filed 2023-03-30 | $622.06K 10-K/A · filed 2023-03-30 |
| 2021-09-30 | $399.82K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $428.19K derived: sum of 2 quarters · filed 2022-11-08 | $450.23K 10-Q · filed 2022-11-08 | $462.50K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $28.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $50.41K 10-Q · filed 2022-08-04 | $62.68K derived: sum of 3 quarters · filed 2022-08-04 | $91.94K derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $22.04K 10-Q · filed 2022-05-10 | $34.30K derived: sum of 2 quarters · filed 2022-05-10 | $63.57K derived: sum of 3 quarters · filed 2022-05-10 | |
| 2020-12-31 | $12.27K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $41.53K derived: sum of 2 quarters · filed 2022-03-22 | $92.87K 10-K · filed 2022-03-22 | |
| 2020-09-30 | $29.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $80.60K 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | $51.33K 10-Q · filed 2021-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |